Tourmaline Bio, Inc.(TRML)
A biotechnology company being acquired by Novartis.
1 Insight
Investment Insights
AI-generated insights about Tourmaline Bio, Inc. from various financial sources
Tuesday, September 9, 2025
Very Bullish
Set to be acquired by Novartis, which is a very bullish event for the stock of the company being acquired.
Tuesday, September 9, 2025
Very Bullish
Set to be acquired by Novartis, which is a very bullish event for the stock of the company being acquired.